Treating Acute Severe Eosinophilic Asthma with IL-5 Inhibitors in ICU
Introduction. About 10% of the 300 million people worldwide who suffer from asthma have a severe disease that is uncontrolled despite treatment with inhaled corticosteroids and long-acting beta agonists. The eosinophilic inflammation pathway in the respiratory tract and blood is involved and interle...
Saved in:
Main Authors: | Nicolas Barbarot, Emmanuelle Nourry, Nicolas Massart, François Legay, Matthieu Debarre, Pierre Fillatre, Eric Magalhaes, Arnaud Mari, Julien Wallois, Eric Briens, Stéphane Jouneau |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Pulmonology |
Online Access: | http://dx.doi.org/10.1155/2022/2180795 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urinary Eosinophil Protein X in Childhood Asthma: Relation with Changes in Disease Control and Eosinophilic Airway Inflammation
by: Marianne Nuijsink, et al.
Published: (2013-01-01) -
Biological treatment options for eosinophilic asthma, with consideration of markers of eosinophilic inflammation as predictors of treatment efficacy
by: Aleksandra Niemiec, et al.
Published: (2024-02-01) -
Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma
by: Girolamo Pelaia, et al.
Published: (2015-01-01) -
Eosinophilic Cystitis with Eosinophilic Cholecystitis: A Rare Association
by: F. Mallat, et al.
Published: (2013-01-01) -
Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function
by: Karina Jahnz-Ró̀zyk, et al.
Published: (2000-01-01)